Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.

Gupta, Simple; Shyamsundar, K; Agrawal, Mohini; Vichare, Nitin; Biswas, Jyotirmay

Gupta, Simple; Shyamsundar, K; Agrawal, Mohini; Vichare, Nitin; Biswas, Jyotirmay.

Afiliación

Gupta S; Department of Ophthalmology, Command Hospital, Pune, India.
Shyamsundar K; Department of Ophthalmology, Command Hospital, Pune, India.
Agrawal M; Department of Ophthalmology, Command Hospital, Pune, India.
Vichare N; Department of Ophthalmology, Command Hospital, Pune, India.
Biswas J; Department of Uveitis and Ocular Pathology, Sankara Netralaya, Chennai, India.

J Ocul Pharmacol Ther ; 38(3): 203-222, 2022 04.

Article en En | MEDLINE | ID: mdl-35133890

Asunto(s)

Biosimilares Farmacéuticos; Uveítis; Adalimumab/uso terapéutico; Biosimilares Farmacéuticos/uso terapéutico; Humanos; Inflamación/tratamiento farmacológico; Infliximab/uso terapéutico; Interleucinas/uso terapéutico; Factor de Necrosis Tumoral alfa

Palabras clave

JAK-inhibitors; anti-TNF-α; biologics; interleukins; noninfectious; uveitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Uveítis / Biosimilares Farmacéuticos Idioma: En Revista: J Ocul Pharmacol Ther Asunto de la revista: FARMACOLOGIA / OFTALMOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google